Coiled Therapeutics (LSE:COIL) Construction In Progress: £0.00 Mil (As of Dec. 2025)


What is Coiled Therapeutics Construction In Progress?

Coiled Therapeutics LSE:COIL Construction In Progress is £0.00 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Coiled Therapeutics Construction In Progress Historical Data

* Premium members only.

The historical data trend for Coiled Therapeutics's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coiled Therapeutics Construction In Progress Chart

Coiled Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
0.00 0.00 0.00 0.00 0.00

Coiled Therapeutics Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Coiled Therapeutics Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of £0.00 Mil mean?
Coiled Therapeutics (LSE:COIL) has a Construction In Progress of £0.00 Mil as of Dec. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on Coiled Therapeutics and its competitors.
Is Coiled Therapeutics' Construction In Progress too high?
Coiled Therapeutics' current Construction In Progress is £0.00 Mil.
How does Coiled Therapeutics' Construction In Progress compare to VRTX and REGN?
Coiled Therapeutics' Construction In Progress of £0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Coiled Therapeutics and its competitors. Coiled Therapeutics's current Construction In Progress is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coiled Therapeutics stock overvalued right now?
Coiled Therapeutics (LSE:COIL) has a current Construction In Progress of £0.00 Mil. The current Construction In Progress is £0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Coiled Therapeutics (LSE:COIL), the current Construction In Progress is £0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Coiled Therapeutics Business Description

Other Exchanges COTXF:USA0AG0:Germany
Address 85 Great Portland Street, First Floor, London, GBR, W1W 7LT
Coiled Therapeutics PLC principal activity of the Company is to develop pre-clinical next generation medicines focused on hard-to-treat cancers. The Group operated in the single business segment of biotechnology.